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ABSTRACT
RNA is ideally suited for in vitro evolution experi-
ments, because a single RNA molecule possesses
both genotypic (replicable sequence) and phenoty-
pic (selectable shape) properties. Using systematic
evolution of ligands by exponential enrichment
(SELEX), we found a single 58-nt aptamer sequence
that assumes two structures with different func-
tions, both of which are required to inhibit the
GluR2 AMPA receptor channel. Yet, the two struc-
tures, once formed during transcription, appear to
be incapable of interconverting through unfolding
and refolding, presumably due to their extraordinary
structural stability. Thus, our results suggest more
broadly that natural RNA molecules can evolve
to acquire alternative structures and associated
functions. Such divergence of RNA phenotype may
precede gene duplication at the genome level.
INTRODUCTION
Both theoretical (1) and experimental (2) work demon-
strated that a single RNA sequence can assume multiple,
distinctly folded structures with diﬀerent functions. These
structures, or more precisely conformations, are diﬀerent
structural folds of the same sequence generated through
reversible thermodynamic pathways. For example, a
selected RNA sequence can adopt a fold that catalyzes
RNA cleavage or a diﬀerent fold that catalyzes RNA liga-
tion (2). On binding of small metabolites, riboswitches can
switch their conformations and consequently functions
(3). However, here we describe that a single RNA
sequence assumes two structures with diﬀerent functions,
both of which are required to work together in order
to inhibit the GluR2 AMPA receptor. Yet, the two struc-
tures, once formed during transcription, are not inter-
convertible through unfolding and refolding or refolding
after denaturation.
The sequence we present corresponds to an aptamer,
which we termed as AN58. AN58 was derived from its
predecessor RNA of 99-nt (i.e. aptGluR2-99) by sequence
reduction, and aptGluR2-99 was evolved from systematic
evolution of ligands by exponential enrichment (SELEX)
(4,5) against the GluR2 receptor (6) from an RNA library
containing  10
15 sequences. AN58 is a minimal, func-
tional aptamer, compared to aptGluR2-99, whereas
RNAs shorter than the 58-nt sequence, such as 53nt
(ﬁve more base deletion from the 30-end of AN58), lost
all inhibitory activities against GluR2 (6). GluR2 is one of
the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid (AMPA) receptor subunits of the glutamate ion chan-
nel family, and it plays a key functional role in brain
activities such as learning and memory (7,8). Excessive
activity of the GluR2 AMPA receptors has been impli-
cated in a number of neurological diseases, and therefore
aptamers as inhibitors might be useful as pharmacological
tools (8).
MATERIALS AND METHODS
Transcription and purification of M1 and M2
The enzymatic transcription reaction of the AN58 DNA
template generated two RNA species, which we termed
as M1 and M2. The in vitro transcription was carried
out using the MEGAshortscript T7 transcription kit
(Ambion) with a 1:1 mixture of the single stranded
DNA template synthesized based on the complementary
sequence of AN58 and the T7 promoter oligo, i.e. 50-TAA
TACGACTCACTATA-30. The M1 and M2 were sepa-
rated from the transcription reaction mixture in a Prep
Cell polyacrylamide gel electrophoresis (PAGE) column
(Bio-Rad) and were individually passed through a Q
column (Bio-Rad) to remove polyacrylamide bound to
RNA samples, as monitored in NMR (6). The pooled
sample was then dialyzed against an appropriate buﬀer,
such as the external buﬀer for electrophysiology (150mM
NaCl, 3mM KCl, 1mM CaCl2, 1mM MgCl2,5 0 m M
HEPES, pH 7.4), and concentrated using an Amicon
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sized that the puriﬁcation of M1 and M2, described
above, was necessary to ensure that the inability of inter-
conversion between M1 and M2 (as shown in Figure 4A)
was not due to the presence of acrylamide bound to these
RNA molecules, causing an artiﬁcial stabilization of M1
and M2 in the folding/refolding experiments.
Transcription and purification of AN59 M1 and AN59 M2
by using glmS ribozyme
To create an even 30-end of M1 and M2 species by in vitro
transcription reaction, we cloned AN58 DNA sequence
into pRAV23 vector (9) that contains the sequence of
the glmS ribozyme (10). In our construct, the AN58
DNA sequence was ligated into the EcoR I( 5 0-) and
Kpn (30-) sites, respectively, and the AN58 sequence was
inserted upstream of the glmS sequence with an additional
nucleotide A. The glmS ribozyme cleaved the RNA
sequence at the AG site upstream at its 30-end, releasing
a single, cleavage fragment (10). Therefore, the con-
structed plasmid was linearized and used as the tem-
plate for in vitro transcription of AN59 M1 and AN59
M2. After transcription reaction by using the
MEGAshortscript T7 RNA kit, the transcription product
was incubated with 1mM glucosamine-6-phosphate
(Sigma), a metabolite that accelerates the cleavage reac-
tion, for 2h in a buﬀer containing 50mM Tris–HCl (pH
7.4), 10mM MgCl2 and 200mM KCl. The reaction mix-
ture, which contained AN59 M1/M2, was separated
through a PAGE column and further puriﬁed by passing
through a Q column, as described above for the AN58
M1/M2 puriﬁcation.
Modification of RNA with glyoxal and characterization
of the glyoxalation products
To evaluate the electrophoretic mobility of AN58 M1 and
M2 without interference of base paring, we treated M1
and M2 with glyoxal (11). Glyoxalation introduces a
bulky adduct into guanosine residues, which then steri-
cally hinders GC-pair formation (11). Experimentally,
100ng of an RNA sample in 5ml was mixed with equal
volume of glyoxal loading buﬀer (supplied by Applied
Biosystems/Ambion and it contained glyoxal, DMSO,
ethidium bromide and bromophenol blue). The mixture
was incubated at 508C for 1h. After incubation, the
sample was kept on ice before loading on a 1 3-morpho-
linopropanesulfonic acid (MOPS) buﬀered, 10% native
PAGE. The electrophoresis was run in 1   MOPS
buﬀer at a constant voltage of 5V/cm (12). The gel was
stained by using SYBR Gold (Invitrogen) and visualized
under UV illumination.
Primer extension
A 10-nt oligo (i.e. 50-GGACGAAACT-30) complementary
to the 30-end of AN58 was 50-
32P-labeled using [g-
32P]ATP
with T4 polynucleotide kinase (Ambion). The cDNA was
synthesized by using a primer extension reaction contain-
ing 1.25mM of each dNTP (GCAT), 5mM DTT and 200
units of Superscript III reverse transcriptase (Invitrogen).
The mixture was ﬁrst treated with RNase H (New
England Biolabs) and was loaded on an 8% polyacryla-
mide sequencing gel containing 8M urea. The radioactiv-
ity of a reverse transcription (RT) reaction was detected
by exposing the gel to a phosphorimage screen (GE
Healthcare), which was digitized in a PhosphorImager
(Typhoon Trio, GE Healthcare). The intensity of the
radioactivity was quantiﬁed by using ImageQuant TL
(GE Healthcare).
Dideoxy-mediated RNA sequencing
A 15-nt oligo (50-GGACGAAACTTGTCC-30) comple-
mentary to the 30-end of AN58 was 50-
32P-labeled using
[g-
32P]ATP as described in Primer Extension. The
dideoxy-mediated RT reaction consisted of 5pmol RNA,
0.5pmol of 15-nt oligo, 25% dimethyl sulfoxide (DMSO),
50mM Tris–HCl (pH 8.3), 40mM KCl, 8mM MgCl2,
1mM dithiothreitol, 0.75mM dNTP and 0.225mM
ddNTP. The reaction was carried out in the presence of
an enhanced avian reverse transcriptase (Sigma) at 428C
for 1h. The sample was treated using RNase H (New
England Biolabs) and run through a sequencing PAGE
gel. The sequence was visualized through the radioactivity
as described above and was conﬁrmed using the syntheti-
cally made AN58 or SynAN58 whose sequence was known
(Trilink Biotechnologies, San Diego, CA).
In-line probing
RNA samples used for in-line probing were puriﬁed by
running through an XBridge C18 column (Waters) on a
Waters Breeze HPLC system, and the column was main-
tained at 558C throughout the puriﬁcation. The running
buﬀer contained 5% methanol in triethylamine/hexaﬂuor-
oisopropanol solution (TEA/HFIP, 16.3mM/400mM,
pH 7.9). A sample was eluted using the same buﬀer but
with a linear gradient of increasing methanol concentra-
tion up to 30%. A puriﬁed RNA sample was 50-
32P-
labeled using [g-
32P]ATP and was puriﬁed through a
10% native PAGE. The RNA sample obtained from the
gel was ethanol precipitated, air dried and re-dissolved in
10mM Tris–HCl buﬀer (pH 7.4). SynAN58 RNA was
used as the control, which was prepared in the same
way. The in-line probing experiments were carried out
by the following procedure. Samples were mixed with
external buﬀer (note that the pH was adjusted to pH
8.6) and kept at 378C for up to 72h. The samples were
then ethanol precipitated, air dried, and re-dissolved in
5mM Tris–HCl buﬀer containing 47.5% formamide. All
of the samples were loaded onto a 12% sequencing PAGE
containing 8M urea. The gel was dried, which was then
exposed to a phosphorimage screen. The image was cap-
tured by a phosphorimage scanner and analyzed by
ImageQuant TL.
Selective 2’-hydroxyl acylation analyzed by primer
extension (SHAPE)
SHAPE experiments were carried out to probe the struc-
tures of M1, M2 and SynAN58. For the SHAPE experi-
ment, an RNA sample was dissolved in 10mM Tris buﬀer,
and the salt concentration was adjusted to (in mM) 150
NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES (pH 7.4).
Nucleic Acids Research, 2009,Vol.37, No. 12 4023The sample was heated to 958C for 3min, placed on ice for
1min and then was left at 378C for 30min.
N-Methylisatoic anhydride (NMIA) dissolved in DMSO
was added to the sample, which reacted with the
20-hydroxyl group of a ribose, generating a corresponding
ester adduct (13). The NMIA reaction was run at 378C
for 50min. The sample was then ethanol precipitated, air-
dried and re-dissolved into dH2O for primer extension.
The primer extension reaction was run by the method
described earlier, except that a 15-nt oligo, 3P15 (50-GG
ACGAAACTTGTCC-30), was used.
Receptor expression
The homomeric GluR2Qﬂip AMPA receptor channel
was transiently expressed in human embryonic kidney
(HEK)-293S cells as described (14). The cells were main-
tained in Dulbecco’s modiﬁed Eagle’s medium supplemen-
ted with 10% fetal bovine serum, in a 378C, 5% CO2,
humidiﬁed incubator. The cells were used for electrophy-
siology from 48h after transfection.
Electrophysiology
The inhibitory function of an aptamer was measured using
whole-cell recording, as described previously (6,15).
Brieﬂy, the electrode had a resistance of  3M  after it
was ﬁlled with the electrode solution (in mM): 110 CsF, 30
CsCl, 4 NaCl, 0.5 CaCl2, 5 EGTA, and 10 HEPES (pH 7.4
adjusted by CsOH). All reagents, including aptamers and
glutamate, were dissolved in the external buﬀer and used
for whole-cell recording. The external buﬀer composition
was described earlier in puriﬁcation of M1 and M2 of the
‘Materials and methods’ section. A solution ﬂow device
(14) was used to apply glutamate in the absence and pres-
ence of an aptamer to an HEK-293 cell expressing the
receptor. Glutamate-induced whole-cell current was
recorded at  60mV and 228C. Unless noted otherwise,
each data point in Figure 1C and 1D was an average of
at least three measurements collected from at least three
cells. Origin 7 was used for data analysis and plotting.
Uncertainties reported refer to standard deviation from
the mean.
RESULTS
Different functional roles of M1 and M2
We previously showed that RNA aptamer AN58 and
its longer versions were all potent inhibitors of GluR2
AMPA receptors (6). In a native PAGE (Figure 1A),
AN58 and its longer versions exhibited two or more
than two bands. Surprisingly, however, the two bands of
AN58, generated by in vitro transcription and labeled as
M1 and M2 in Figure 1A, did not individually inhibit the
GluR2 receptor, as characterized by whole-cell recording
of the GluR2 receptor channel expressed in HEK-293 cells
(14) (Figure 1B). Yet, when mixed with equal molar ratio,
M1 and M2 inhibited the receptor as fully as they did
before they were separated (Figure 1C).
More surprisingly, M1 and M2 were found to have
diﬀerent functional roles in inhibiting the GluR2 receptor,
a conclusion drawn from a series of whole-cell current
recording experiments (Figure 1D). First, an equal
molar mixture of the non-inhibitory 53-nt transcript
(AN53) with the puriﬁed M2 yielded no inhibition, but
the mixture of the 53-nt transcript with the puriﬁed M1
produced an inhibition as strong as the mixture of puriﬁed
M1 and M2 (Figure 1D). As a control, RN87 whose RNA
sequence is diﬀerent from either AN58 or AN53 showed
no inhibition itself or when mixed with either M1 or M2
(Figure 1D). These results (Figures 1C and D) indicated
that M1 and M2 functioned diﬀerently, by binding sepa-
rately to two diﬀerent sites, but M1 and M2 were required
to act as a collaborating pair to inhibit GluR2 (Figure 1E).
We previously concluded that AN58 was a competitive
inhibitor based on the fact that the original sequence of
AN58 was evolved from SELEX using 6-nitro-7-
sulfamoylbenzo[f]quinoxaline-2,3-dione (NBQX) as the
selection pressure to displace aptamers from their binding
sites or a site that was mutually exclusive (6), and that
the NBQX is a classic competitive inhibitor of the
AMPA/kainate subtypes of glutamate receptors (16).
Furthermore, AN58 was shown to displace NBQX
bound to the receptor in a radio-ligand binding assay
and also to right-shift the dose-response curve established
by whole-cell current recording (6). Based on this mecha-
nism of the collective action of M1 and M2 (Figure 1E),
the intrinsic inhibition constant or KI for M1 and M2 was
estimated to be 25 4 and 27 7nM, respectively
(Supplementary Figure 1). The experiment using diﬀerent
ratios of M1 and M2 further revealed that the relative
stoichiometry of the inhibition was 1:1 (Supplementary
Figure 1).
Sequencing of M1 and M2
Based on the ﬁnding that M1 and M2 had diﬀerent func-
tional roles but had to act together in order to inhibit the
receptor (Figure 1C and D), we hypothesized that the
functional diﬀerence between M1 and M2 was a result
of diﬀerent structures assumed from the same sequence.
To test this hypothesis, we ﬁrst sequenced M1 and M2 by
primer extension, using the synthetically made AN58 or
SynAN58 with the known sequence as the ladder. As
expected, the sequence of M1 and M2 was identical
(Supplementary Figure 2) (note that the 30-end sequence
was not resolved due to the annealing of a 15-nt primer for
the sequencing). Using either a 12-nt or 17-nt primer
annealed at the 30-end also produced the same sequencing
information for M1 and M2 (data not shown). We further
demonstrated that M1 and M2, once chemically modiﬁed
by glyoxal, were able to migrate with the same mobility
(Figure 2A) in PAGE, suggesting that M1 and M2 also
had the same length. The use of glyoxal to completely
denature RNAs by glyoxalating their bases, thus prohibit-
ing base pairing, allowed RNAs to migrate in PAGE
without interference of secondary structures (11).
Structural differences in M1, M2 and SynAN58
Evidence that M1 and M2 had the same length, resolved
in glyoxal/PAGE (Figure 2A), and the same sequence,
revealed by primer extension (Supplementary Figure 2),
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native (Figures 1A and 2A) and denatured PAGE
(Figure 4A) suggested that M1 and M2 had diﬀerent sec-
ondary and perhaps tertiary structures. Indeed, the primer
extension reaction by using the same 30-end primer
revealed a diﬀerence in the reverse transcription or RT
pattern between M1 and M2 (Figure 2B). The existence
of intermediate RT stops or pauses during elongation of
reverse transcription, like those observed here, is known to
be induced by structured regions in an RNA template
(17,18). As such, the diﬀerent RT pause patterns at vari-
ous nucleotide positions between M1 and M2 supported
the notion that M1 and M2 assumed two distinct struc-
tures from the same sequence (see the bar chart in
Figure 2B).
We further preformed in-line probing experiment with
M1 and M2, using SynAN58 as a control (Figure 2C). The
in-line probing experiment was useful because it directly
revealed the precise nucleotide positions that deﬁne the
structural diﬀerences between M1 and M2 even possibly
in the last 15-nt region that was not observable in primer
extension experiments, such as in the RT stop patterns (or
Figure 2B). In-line probing experiment is based on the
inherent intramolecular phosphoester transfer or transes-
teriﬁcation reaction of an RNA due to a nucleophilic
attack by the 20 oxygen from the 20-OH group on the
adjacent phosphorus atom, severing internucleotide link-
age (19). The transesteriﬁcation reaction occurs when
the 50-oxyanion leaving group is positioned directly at or
‘in-line’ with the opposing side of the target phosphorus
center relative to the nucleophile (19–21). Therefore, inter-
nal RNA structures aﬀect, as anticipated, the rate of the
transesteriﬁcation reaction (19). For this reason, in-line
probing is a sensitive method to detect subtle structural
diﬀerence in RNA without any chemical labeling of the
RNA. As seen in Figure 2C, robust cleavage was observed
in M2 but not in M1 in the regions of A49–A46 and of
G37–G15. The diﬀerence in the in-line probing pattern
covering a wide sequence range, i.e. A49–A46 and of
G37–G15, suggested that the secondary (and tertiary)
structure of M1 is quite diﬀerent from M2 and that M1
might be folded to a greater complexity in its secondary
and tertiary structures that were less prone to cleavage
(19). Furthermore, internucleotide linkages near the ends
of RNA are generally more susceptible to cleavage (22),
presumably due to RNA fraying (23,24). In fact, M2 (and
even M1) showed a greater tendency of fragmentation at
both ends, as compared with its middle part of the struc-
ture. Surprisingly, however, the 30-end region of
SynAN58, i.e. C57–G55, exhibited a much stronger resis-
tance to cleavage than both M1 and M2, despite the fact
that M2 was generally similar in cleavage pattern to
SynAN58. The structural uniqueness of the C57–G55
region in SynAN58 is currently unknown. However, the
C57–G55 region was critical because deletion of the last
ﬁve bases at the 30-end, which covered this region, led to
the total loss of inhibitory activity for either the synthetic
RNA (i.e. SynAN53) or the enzymatic transcript of AN53
Figure 1. Diﬀerent functional (inhibitory) roles of M1 and M2. (A) M1 and M2 derived from AN58 were visualized in native PAGE (10%) by
ethidium bromide staining, together with its longer versions, i.e. 87-nt and 99-nt (i.e. aptGluR2-99) aptamers. RNA Century marker (Applied
Biosystem) was loaded in the ﬁrst lane and the lowest band corresponded to 100-nt length. (B) Representative whole-cell current response of
GluR2Qﬂip expressed in HEK-293 cells to 500mM glutamate in the absence (left panel) and presence (right panel) of 30nM AN58 (unless otherwise
noted, 500mM glutamate was used for all the assays in this study). (C) M1 or M2 alone caused no inhibition but an equal molar mixture of M1 and
M2 restored the inhibition of GluR2 to the same level by the non-separated AN58 at identical concentrations. (D) Mixing of AN53 with M1, but not
M2, yielded inhibition, but AN53 alone did not inhibit the receptor. As a control, the mixture of M1 and another non-functional RNA, RN87,
caused no inhibition. (E) As a competitive inhibitor pair, M1 and M2 are proposed to bind to their corresponding sites simultaneously and in 1:1
stoichiometry ratio (see Supplementary Figure 1) to block the entry of glutamate to its binding site.
Nucleic Acids Research, 2009,Vol.37, No. 12 4025(Figure 1D). Together, these results support the hypothe-
sis that M1 and M2 can assume two distinct structural
folds encoded by the same sequence. Furthermore, the
synthetic AN58 seemed to have a structure diﬀerent
from either M1 or M2 despite the fact that SynAN58
shared the same sequence with the enzymatic transcripts
M1 and M2 (Supplementary Figure 2).
SHAPE analysis of M1, M2 and SynAN58
The ribose 20-hydroxyl group of an RNA is known to
react with NMIA to form ester adducts at the 20 position,
but the acylation reactivity is inﬂuenced by the local struc-
ture such that a ﬂexible nucleotide reacts with NMIA
more readily than a nucleotide constrained by either
base pairing or a tertiary interaction (13). Therefore, the
Figure 2. Structural diﬀerences in M1, M2 and SynAN58. (A) Glyoxal-treated M1 and M2 exhibited the same mobility in a 10% PAGE using a
MOPS running buﬀer (20mM MOPS or 3-(N-morpholino)propanesulfonic acid, 2mM sodium acetate, 1mM EDTA, pH 7.2). Without glyoxal
treatment, M1 and M2 ran with diﬀerent mobility under the same electrophoresis condition or even in denaturing PAGE (see Figure 4A, middle
panel). (B) Primer extension of both M1 and M2 using a 50-
32P-labeled 10-nt oligo primer. The four lanes on the left were sequencing ladders; and
the SynAN58 was used as the control (middle lane). Shown on the right is a bar chart indicating the diﬀerence of RT stops in terms of the ratio of
the intensity of radioactivity, which linked these stops to speciﬁc positions of the nucleotide in both M1 and M2. (C) In-line probing of M1 and M2.
The ﬁrst and the second lane were an alkaline hydrolysis ladder and an RNase T1 cutting ladder produced from SynAN58. All samples were kept in
the external buﬀer (see the buﬀer composition in Materials and Methods) at 378C for zero, 24 and 72h as indicated (note that, although not shown,
all of the samples could be eventually degraded completely or to single bases given enough time). The diﬀerence in the degradation pattern between
M1 and M2 is marked in green color frame on the right. Similarly, the diﬀerence in the degradation pattern or the sequence region between
SynAN58 and M2 is marked in red. All of the samples were 50-end labeled and separated in a 12% sequencing PAGE containing 8M urea.
4026 Nucleic Acids Research, 2009, Vol. 37,No. 12reactivity of the acylation can be used to reveal locations
of those conformationally dynamic nucleotides in an
RNA. Experimentally, the reactivity can be detected by
primer extension experiment because the formation of a
20-ester adduct causes a RT stop (13). Using NMIA, we
performed SHAPE experiment to probe the conforma-
tional dynamics of the structure for M1, M2 and
SynAN58. Shown in Figure 3A is the gel electrophoresis
analysis of the reactivity of NMIA at single nucleotide
position up to nucleotide 43 (whereas the last 15nt in
the 58-nt RNA were covered by the primer annealing).
The band intensities in the gels, which reﬂected RT
stops, were quantiﬁed, using SAFA program, and the
SHAPE reactivity for each species was calculated by a
method previously described (25).
Based on the quantitative SHAPE reactivity
(Figure 3B), both the overall number of nucleotides that
were labeled and their respective positions were diﬀerent
for M1, M2 and SynAN58, consistent with the notion that
each of the three species had a distinct structure. In partic-
ular, M1 had the least number of the nucleotide positions
labeled overall. Furthermore, in the two major segments
where both M2 and SynAN58 reacted prominently with
NMIA, e.g. A18–A22 and A33–A36, the same nucleotides
Figure 3. SHAPE analysis of M1, M2 and SynAN58. (A) The pattern of NMIA reactivity was probed by a reverse transcription reaction using a 50-
end, 15-nt oligo or 3P15, and visualized on a 12% denaturing PAGE containing 8M urea. Other parameters were described in ‘Materials and
Methods’ section. The sequencing ladder, shown on the right, was generated by dideoxy nucleotide incorporation during the primer extension, similar
to Figure 2B. (B) Band intensity in the presence and absence of NMIA was quantiﬁed by using SAFA software (38). For each nucleotide position,
the reactivity was calculated as the intensity diﬀerence between the NMIA labeled lane and the negative control lane; the negative control
corresponded to a 10% DMSO (ﬁnal concentration) in the same reaction mixture but without NMIA. There were also nucleotide positions
where no reactivity could be detected or a negative reactivity was detected, due to strong RT stops in the absence of NMIA (Figure 2B). These
positions, along with the last 15nt for primer annealing, all marked in light gray in Figure 3C, were set to be zero in the reactivity value. The SHAPE
reactivity score was calculated based on a method described previously (25,27). The long-dashed blue line indicates the threshold of 0.75 SHAPE
reactivity score whereas the short-dashed line represents the threshold of 0.35 SHAPE reactivity score (see text for detailed explanation). (C)
Secondary structures generated using RNAstructure (version 4.6) (26), based on the SHAPE reactivity score. The number of the structures displayed
corresponded to those whose free energy diﬀered by less than 10% from the lowest free energy in each of the structures.
Nucleic Acids Research, 2009,Vol.37, No. 12 4027in M1 exhibited no NMIA reactivity. In general, non-
reactive nucleotides were thought to be Watson–Crick
base-paired. A number of non-canonical base pairing,
such as U–G, A–A and A–G, could also become nonreac-
tive. We therefore concluded that a major network of base
pairing and possibly tertiary interactions existed in M1,
rendering only a few nucleotide residues solvent accessible.
This conclusion is also consistent with result from the
in-line probing experiment with M1 (Figure 2C), where
a large portion of its structure showed considerable resis-
tance to degradation on the same time scale, as compared
with either M2 or SynAN58.
In contrast, the overall patterns of SHAPE reactivity
between M2 and SynAN58 were similar (Figure 3B), sug-
gesting the two were structurally similar. However, there
were still clear diﬀerences. For instance, the SHAPE reac-
tivity terminated at A36 for SynAN58, whereas it contin-
ued from G37–U42 for M2. This result indicated that the
30-region may be the location that distinguishes M2 from
SynAN58. Consistent with this result, the in-line probing
experiment showed that M2 and SynAN58 had key struc-
tural diﬀerence in G55–C57 at the 30-end (these nucleo-
tides were not detectable in SHAPE experiment because
they were part of the primer annealing site). It is further
worth noting that in between G37–U42, SynAN58 showed
no SHAPE reactivity, while M1 was labeled but only at
U39 and U42, as compared to a broader reactivity in M2.
Together, these results highlight the importance of the
30-region in deﬁning the uniqueness of the structures of
these species.
Based on both the primary RNA sequence and more
importantly the three sets of SHAPE reactivity scores
(Figure 3B), we further predicted the secondary structures
for M1, M2 and SynAN58, using an RNA structure
prediction algorithm (26). The SHAPE reactivity was
especially useful in the secondary structure prediction,
because it provided experimental evidence to constrain
the locations of the conformationally dynamic nucleotides
(25). However, it should be noted that the following fac-
tors were taken into consideration in structural prediction
(25,27). First, the reactivity score of 0.75 (i.e. the long-
dashed line in Figure 3B and the nucleotides colored in
red in Figure 3C) corresponded to the threshold of single-
stranded, highly reactive nucleotide residues. The reactiv-
ity score between 0.75 and 0.35 (i.e. the short dashed-line
in Figure 3B and the nucleotides colored in orange in
Figure 3C) was considered to be those that were either
base-paired or adjacent to bulges, mismatches, or G-U
pairs, which could be more dynamic than nucleotides in
the center of an uninterrupted helix. For the reactivity
score below 0.35, however, the nucleotides were thought
to be base-paired (25,27). According to these SHAPE
reactivity constraints, the secondary structures were gen-
erated for M1, M2 and SynAN58 (Figure 3C). As seen
(Figure 3C), their secondary structures are clearly diﬀer-
ent. For instance, in the constant region of the RNA
aptamer or nucleotides of G1–C25 (6), a stem-loop was
predicted (Figure 3C), supported by the SHAPE reactivity
at some nucleotides in both M2 and SynAN58. However,
the lack of NMIA reactivity in M1 roughly in the same
loop position suggested that M1 might have a more
complex structure involving with this region, such as its
participating in a tertiary interaction. Furthermore, for
both M1 and M2, there seemed to be another stem-loop
near A40. However, such a region showed no SHAPE
reactivity for SynAN58 (Figure 3C). The lack of the
SHAPE reactivity near A40 for SynAN58 suggested
a conformationally constrained local structure or is
indicative of the involvement of this loop in a tertiary
interaction.
M1 and M2, two non-convertible RNA folds
To begin to understand the structure-function relationship
of the three RNA species, M1, M2 and their synthetic
counterpart, SynAN58, we ﬁrst asked whether M1 and
M2 were interconvertible folds. If so, one species would
be a transcription product whereas the other was the prod-
uct of folding. To answer this question, we attempted
to unfold and refold M1 and M2. However, even after
boiling or ethanol precipitation or freezing, M1 and M2
remained individual bands, as visualized on native PAGE,
and their biological activities also remained intact, as
tested by whole-cell recording. After boiling in the pres-
ence of  50% formamide for 15min, M1 did partially
unfold into a species that had mobility seemingly identical,
on denaturing PAGE, to that of M2 (Figure 4A, the
middle panel; the lower band of the M1). However, the
lower band originating from the M1 sample disappeared
upon refolding, suggesting that M1, under such a harsh
denaturing condition, could partially unfold to some other
structure(s) but not to M2. M2, on the other hand,
appeared intact after such treatments as it remained a
single band. We also attempted to denature M1 and M2
by raising solution pH to an extreme (28). In this experi-
ment, a brief (i.e. 3min) exposure of 10mM NaOH
(i.e. pH  12) readily caused degradation or alkaline
hydrolysis of both M1 and M2 but not denaturation or
interconvertion from one to the other (Supplementary
Figure 3). Based on these results, we concluded that M1
and M2 were not diﬀerent conformers or products of
folding/refolding. Instead, M1 and M2 were diﬀerent
structural entities assumed from the same sequence.
It should be noted that for drawing the conclusion as
stated above, we also carried out a control experiment.
Speciﬁcally, we constructed a 59-nt RNA producing plas-
mid (i.e. pRAV–AN59; see the ‘Materials and Methods’
section), which contained the glmS ribozyme sequence (9)
linked to the 30-end of the AN58 sequence. As the glmS
ribozyme spliced between the AG sites (29), the 59-nt
RNA that contained the AN58 aptamer sequence with
an additional ‘A’ at the 30-end was produced. As expected,
the 59-nt RNA aptamer appeared as two bands at the sim-
ilar positions on a native PAGE, which were simi-
larly termed AN59 M1 and AN59 M2 (Figure 4B).
Furthermore, AN59 M1 and AN59 M2 had identical
length (see their LC–MS mass spectra in Supplementary
Figure 4). More importantly, AN59 M1 and AN59 M2
exhibited the same properties as M1 and M2 (or AN58
M1 and M2) in that they were not interconvertible when
subject to the same unfolding/refolding experiments
(Figure 4B), yet they had inhibitory function identical
4028 Nucleic Acids Research, 2009, Vol. 37,No. 12to AN58 M1/M2, evidenced by the ﬁnding that as a pair,
but not alone, AN59 M1 and AN59 M2 acted as an inhib-
itor on GluR2Qﬂip AMPA receptors and with an identical
inhibitory potency to the AN58 M1/M2 pair (data not
shown). This control experiment demonstrated that the
functional and structural diﬀerence between M1 and M2
were not attributed to the possibility of an uneven length
between M1 and M2.
It is possible, however, that M1 and M2, regardless of
AN58 or AN59 version, might be folded and refolded in
their own repertoires of conformations or folding net-
works (at least this may be true for M1), there is not a
thermodynamic pathway through which a conformation
from one conformational repertoire can become the origin
of the other conformational repertoire (i.e. the so-called
conformational diﬀusion between the two networks) (1).
Although we cannot rule out that there may be yet an
unidentiﬁed denaturing condition under which M1 and
M2 can both be denatured post-transcriptionally, the con-
ditions used in this study are to our knowledge the stron-
gest denaturing conditions known. The lack of an
apparent pathway through which M1 and M2 can be
interconverted by unfolding and refolding or refolding
after denaturation suggests an unusual folding landscape
with an energy barrier that is suﬃciently high to irrevers-
ibly separate the two diﬀerent structures. Thus the struc-
tural diﬀerences between M1 and M2 seem not to be a
result of RNA-folding process or conformational parti-
tioning (1,30).
Co-transcriptional formation of M1 and M2
Our ﬁnding that M1 and M2 are not diﬀerent folds that
can be reversibly formed or interconverted post-transcrip-
tionally by any unfolding/refolding pathway suggests
that both M1 and M2, rather than just one species,
should be enzymatic products of in vitro transcription,
as observed (Figures 1A and 2A). Furthermore, our
results also suggest that the two structural entities, i.e.
M1 and M2, are generated during the transcription or
are co-transcriptional products. Characteristic of an enzy-
matic reaction, both the rate and the yield of the transcrip-
tion reaction of M1 and M2 were shown to depend on
temperature and Mg
2+ concentration (see Figure 4C
and also Supplementary Figure 5). Interestingly, the tran-
scription rate of M2 was always faster than M1 (Figure 4C
and Supplementary Figure 5). How M1 and M2 are
formed during transcription is currently not known. One
possibility is the existence of a nascent knot or a topolog-
ically entangled helix formed during the transcription per-
haps for one or both species, which may set M1 and M2
apart. The interhelical stacking on a basis of a three-way
junction, as in the case of the hammerhead ribozyme,
could provide additional stability through base pairing
between the two closing loops of helices (31). Such a struc-
ture is known to be stable even in as low an Mg
2+ con-
centration as 100mM (32). In our case, the M1 and M2,
once folded during transcription, were stable either alone
or together even at zero concentration of Mg
2+. It should
be also emphasized that M1 and M2 were both the tran-
scription reaction products generated in the presence of
the T7 RNA polymerase, because M1 and M2 were gen-
erated despite the fact that T7 RNA polymerases from
diﬀerent sources, e.g. Ambion transcription kit, and pur-
iﬁed wild type, were used. Furthermore, when the DNA
Figure 4. M1 and M2, the two nonconvertible RNA folds. (A)
Unfolding and refolding of AN58 M1 and M2. The left panel shows
the diﬀerent mobility of puriﬁed M1 and M2 in a native PAGE (10%),
compared with the mixture of the original sample, AN58. When the
puriﬁed M1 and M2 dissolved in the Loading Buﬀer II (Ambion) for
denaturing PAGE, which contained 47.5% formamide (ﬁnal concentra-
tion), were boiled for 15min and run in the denaturing PAGE (10%,
7M urea), additional band appeared originating from the M1 sample
(middle panel). The ‘‘denatured’’ M1 and M2 were then precipitated in
ethanol and re-suspended in the external buﬀer; the refolded samples
were visualized in another native PAGE (10%) (right panel). Note that
in the same native PAGE, the AN58 sample was treated by the same
unfolding/refolding process. The M1 and M2 used in the folding/refold-
ing experiments were also puriﬁed to remove the contaminated acryla-
mide (see ‘Materials and Methods’ section). (B) The same unfolding
and refolding experiment and gel electrophoresis as described in (A) but
with AN59 M1 and AN59 M2. The AN59 aptamer was generated by
using pRAV23 plasmid, and cleaved by glmS ribozyme (see ‘Materials
and Methods’ section). (C) The time course of M1 and M2 transcrip-
tion as visualized in a 10% native PAGE by ethidium bromide staining.
The transcription reaction was carried out at 378C, and the samples
from diﬀerent time points were taken as shown. The line labeled as
AN58 was the transcription product from a 12h reaction. (D) The
chemically synthesized AN58 or SynAN58 showed an electrophoretic
mobility diﬀerent from either AN58 M1 or AN58 M2. (E) The same
unfolding and refolding experiment and gel electrophoresis as described
in (A) but with SynAN58.
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was then subject to a transcription reaction with T7
RNA polymerase, SynAN58 remained intact, namely, it
did not convert to either M1 or M2 (Supplementary
Figure 6). Together, these results show that M1 or M2 is
not a chemically modiﬁed product by any potentially con-
taminating sources such as another enzyme, etc., in the
transcription reaction; rather, M1 and M2 were the tran-
scription products from the T7 RNA polymerase-
catalyzed reaction. However, it should be noted that
these results did not rule out the possibility of a chemical
modiﬁcation of one or both transcripts by T7 RNA poly-
merase during the transcription reaction. Such a chemical
modiﬁcation is possible given the extraordinary stability
of these two species, which made it impossible, at least
with known denaturing agents, to unfold them.
The synthetically made AN58 or SynAN58 was diﬀer-
ent from AN58 M1 and M2 in several ways. First,
SynAN58 appeared as a single band in native PAGE
and exhibited a diﬀerent mobility from either the M1 or
the M2 (Figure 4D). SynAN58 had a diﬀerent RT pause
pattern in the reverse transcription reaction (Figure 2B)
and a diﬀerent in-line probing proﬁle (Figure 2C) from
either the M1 or the M2, although by and large
SynAN58 was more similar to the AN58 M2
(Figures 2C and 3B). Furthermore, SynAN58 inhibited
the GluR2 AMPA receptor with an inhibition constant
being  4-fold lower than transcriptionally generated
AN58 or the mixture of M1 and M2 (6). The apparent
diﬀerences in both the function and the structure between
the synthetically made AN58 and enzymatic products,
although all shared the same sequence, may be due to
the possibility that the folding of an RNA during tran-
scription is known to occur sequentially from the 50-end to
the 30-end of an RNA molecule. The directionality of the
transcription, together with the speed of the transcription
reaction, may create an order of the folding events diﬀer-
ent from the refolding of the full-length RNA with the
same sequence (33,34). The fact that SynAN58 does not
fold into either M1 or M2, even after SynAN58 was sub-
ject to the same denaturation/refolding treatment
(Figure 4E) as in AN58 M1/M2 (Figure 4A) and AN59
M1/M2 (Figure 4B), is further consistent with the hypoth-
esis that M1 and M2 are co-transcriptional products.
Presently, studies using chemical and enzymatic probing
as well as structural techniques, together with mutational
analysis, are ongoing to reﬁne the secondary structures
and to probe the tertiary structures for the three species.
DISCUSSION
The results from this study provide interesting implica-
tions to the evolution of RNA structure and function in
nature. As shown in Figure 4A, for example, it was not
possible to unfold/refold the AN58 M1 and M2 post-tran-
scriptionally, and consequently the M1 and M2 were not
able to convert to each other, despite the fact that the M1
and M2 were assumed from the same sequence. However,
as shown (Figure 2B), both the M1 and M2 could be fully
reverse-transcribed in spite of diﬀerent RT pauses during
elongation. This result suggested that reverse transcriptase
was the ‘denaturant’ to ‘melt’ the RNA during the in vitro
evolution (6). Then the prediction could be made that run-
ning separate reverse transcription/PCR reactions for M1
and M2, the two non-convertible RNA isolates, followed
by two separate in vitro transcriptions, would yield both
M1 and M2 as transcription products, independent of the
input RNA template. In fact, this was exactly what we
found (Supplementary Figure 7). This result further sug-
gested that the original, full-length sequence of AN58 or
aptGluR2-99 that contained the functional M1 and M2
domains would be expectedly capable of surviving pheno-
typic selection, which required reverse transcription in each
SELEX cycle. Clearly, the evolution of the aptamer
sequence (genotype) was driven by the selection of that
aptamer (desired genotype) for its binding to receptor
(35). In fact, AN58 and aptGluR2-99 were both shown
to bind to the extracellular glutamate-binding domain (or
the S1S2 protein) assayed by radio-ligand binding and
were both functionally active as inhibitors of the GluR2
AMPA receptor assayed by whole-cell recording (6).
The results described above suggested that the survival
and evolution of one phenotype (selectable shape), such as
the M1-containing RNA, was enough to ensure the con-
current survival of the other phenotype or the
M2-containing aptamer, because the two phenotypes are
encoded by the same genotype (replicable sequence). Here
evolution can be viewed as a walk over the set of geno-
types preferring ‘ﬁtter’ oﬀspring (36). In our case, because
the two phenotypes are not conformers that are reversibly
interconvertible and because both are selected with dis-
tinct functions, both of them are therefore ﬁtter. The abil-
ity of the same genotype to encode two phenotypes during
the course of evolution is surprisingly and profoundly
meaningful in that the two phenotypes, both of which
are apparently very stable and functionally useful (as
part of the inhibitory pair), must survive through a
shared evolution origin and history. It would be otherwise
almost impossible or too fortuitous that two phenotypes
could have been selected against all odds among a vast
number of possible RNA molecules or selectable shapes.
Thus, our results suggest more broadly that natural RNA
molecules can evolve to acquire alternative structures and
associated functions that are genealogically linked by even
one phenotype.
The transfer of sequence information between two dif-
ferent classes of nucleic acids is not generally considered
diﬃcult because such a process uses the one-to-one corre-
spondence of Watson–Crick pairing (37). However, the
transfer of function is diﬃcult because function is a prop-
erty of a macromolecule that is inherently more complex
than sequence. In a recent study, it was shown that the
evolutionary conversion of a ribozyme (RNA) to a deox-
yribozyme (DNA) of the same function can be accom-
plished but only with some critical sequence mutations
(37). The ﬁnding from this study shows that the survival
of one genotype can entail more than one phenotype
through in vitro evolution, suggesting that transfer of dif-
ferent functions through the same sequence from DNA to
RNA is possible. Furthermore, it is perhaps not surprising
that the structures assumed from the same sequence
4030 Nucleic Acids Research, 2009, Vol. 37,No. 12formed during transcription must be so stable thermody-
namically as to ensure the integrity of a particular func-
tion. Therefore RNA may be more phenotypically
adaptable than proteins, given the fact that unlike RNA,
a real protein does not unify genotype and phenotype in
one molecule (36). Currently, no protein sequence is
known to fold autonomously into two diﬀerent structures
endowing two functions (2). Therefore, our results support
the hypothesis (2), albeit in a diﬀerent way, that RNAs that
show structural dissimilarities with diﬀerent functions can
nevertheless share a common ancestry and bear the same
evolution memory. It is possible that in a real organism a
single RNA sequence could evolve to ‘duplicate’ RNA
molecules with structure-dependent functional dissimilari-
ties, which, in some cases, may precede gene duplication.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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